SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-08 |
| Reported value | $2,054,666,011 |
| Positions | 240 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | LGND | COM NEW | $85,360,737 | 270,052 |
| ACI WORLDWIDE INC | ACIW | COM | $50,621,663 | 1,006,595 |
| ARLO TECHNOLOGIES INC | ARLO | COM | $50,320,328 | 3,732,962 |
| FABRINET | FN | SHS | $49,225,280 | 87,577 |
| ESTABLISHMENT LABS HLDGS INC | ESTA | COM | $48,133,832 | 560,935 |
| XPO INC | XPO | COM | $46,165,205 | 224,878 |
| ZIFF DAVIS INC | ZD | COM | $43,021,746 | 821,496 |
| SHIFT4 PMTS INC | FOUR | CL A | $42,535,291 | 874,492 |
| KINIKSA PHARMACEUTICALS INTL | KNSA | ORD SHS CL A | $39,964,146 | 624,928 |
| ASCENDIS PHARMA A/S | ASND | ORD SHS | $39,646,328 | 148,644 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.